Change gout: how to deal with this 'silently-developing killer' in everyday clinical practice.

Change gout: how to deal with this 'silently-developing killer' in everyday clinical practice. Curr Med Res Opin. 2018 Mar 19;:1-12 Authors: Scirè CA, Rossi C, Punzi L, Genderini A, Borghi C, Grassi W Abstract Despite being regarded as an easily-treatable disease, gout diagnosis and management can be challenging. We discuss here current issues in gout management and propose some potential solutions. Gout diagnosis should be reached as early as possible and often requires specific tests, such as synovial fluid analysis or imaging techniques that are not available in most centers, leaving health care professionals to rely only on clinical presentations and their experience. In addition, gout management requires the evaluation of multiple aspects, such as monitoring of serum uric acid (sUA) level (which should be reduced to <6 mg/dL) to ensure adherence and efficacy of treatment, evaluation of patient's risk profile and comorbidities, and continuous assessments to manage clinical manifestations. An important premise in gout management is non-pharmacological interventions; however, pharmacological urate-lowering therapy is crucial for an optimal control of the disease. Available options include xanthine-oxidase inhibitors (XOI), targeting uric acid overproduction, and uricosuric agents which target the predominant cause of hyperuricemia (underexcretion). Among these, lesinurad is the novel uricosuric agent to be used in combination...
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research